UBS (Lux) Equity Fund - Biotech P Fonds
534,35
EUR
+2,15
EUR
+0,40
%
605,65
USD
-6,58
USD
-1,07
%
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 9,35% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 6,96% |
| AbbVie Inc | US00287Y1091 | 5,53% |
| Gilead Sciences Inc | US3755581036 | 5,16% |
| Neurocrine Biosciences Inc | US64125C1099 | 5,09% |
| Guardant Health Inc | US40131M1099 | 4,42% |
| Amgen Inc | US0311621009 | 4,30% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 3,65% |
| Royalty Pharma PLC Class A | GB00BMVP7Y09 | 3,37% |
| Denali Therapeutics Inc | US24823R1059 | 3,28% |
| Sonstige | 48,89% |